{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T16:18:54Z","timestamp":1792167534434,"version":"4.4.0"},"reference-count":21,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2000,3,1]],"date-time":"2000-03-01T00:00:00Z","timestamp":951868800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2000,3,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Lipodystrophies, characterized by reduction of subcutaneous fat over part or all of the body surface, are uncommon. Their causes are unknown. Recently, lipodystrophy has been reported in human immunodeficiency virus (HIV)-infected patients taking protease inhibitors, which have been recommended since 1996 as standard therapy for HIV disease in combination with nucleoside analogues. In these cases, lipodystrophy consists of an association of peripheral lipoatrophy with central adiposity. We report four HIV-infected men on protease inhibitors who developed a disfiguring lipodystrophy. In three of them, the protease inhibitor was administered for a mean duration of 21\u00b75 months (range 19\u201323) with good immunological and virological responses. Patient 4 had been treated for 2 years with successive combinations of protease inhibitors with nucleoside analogues without success. The four patients progressively developed an increase in abdominal girth associated with fat wasting of the face and legs. Two of them had recurrent paronychia of the great toes. Triglyceride levels were moderately increased in all patients, and one had a slightly increased cholesterol level. One patient had elevated glucose and insulin plasma levels during a glucose tolerance test. In two patients, a deep biopsy taken from the thigh showed thinning of the subcutaneous fat without other morphological changes. Computed tomographic scans of the face and abdomen confirmed the loss of almost all subcutaneous fat of the cheek and temporal regions, and abdominal perivisceral fat accumulation. For patients 1\u20133, the protease inhibitor was replaced by a non-nucleoside reverse transcriptase inhibitor. Nine months later, dysmorphic changes had not regressed, but lipid abnormalities had returned to normal and the paronychia had disappeared.<\/jats:p>","DOI":"10.1046\/j.1365-2133.2000.03363.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T05:24:51Z","timestamp":1047360291000},"page":"496-500","source":"Crossref","is-referenced-by-count":37,"title":["Lipodystrophy associated with protease inhibitors"],"prefix":"10.1093","volume":"142","author":[{"given":"I.","family":"Panse","sequence":"first","affiliation":[{"name":"Departments of Dermatology,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Vasseur","sequence":"additional","affiliation":[{"name":"Departments of Dermatology,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.L.","family":"Raffin-Sanson","sequence":"additional","affiliation":[{"name":"Internal Medicine V and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Staroz","sequence":"additional","affiliation":[{"name":"Histopathology, H\u00f4pital Ambroise Par\u00e9, Assistance Publique\u2014H\u00f4pitaux de Paris, 9 Avenue Charles de Gaulle, 92104 Boulogne, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Rouveix","sequence":"additional","affiliation":[{"name":"Internal Medicine V and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Saiag","sequence":"additional","affiliation":[{"name":"Departments of Dermatology,"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2000,3,1]]},"reference":[{"key":"2023012714365870900_b1","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/S0140-6736(05)63513-1","article-title":"Protease inhibitor-associated hyperglycaemia. (Letter.)","volume":"350","author":"Dube","year":"1997","journal-title":"Lancet"},{"key":"2023012714365870900_b2","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/00002030-199815000-00001","article-title":"Treatment with protease inhibitors associated with peripheral insulin resistance and impaired oral glucose tolerance in HIV-1-infected patients.","volume":"12","author":"Walli","year":"1998","journal-title":"AIDS"},{"key":"2023012714365870900_b3","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1086\/597649","article-title":"Hypertrophy of the breasts in a patient treated with indinavir.","volume":"25","author":"Herry","year":"1997","journal-title":"Clin Infect Dis"},{"key":"2023012714365870900_b4","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/S0140-6736(97)11443-X","article-title":"\u2018Buffalo hump\u2019 in men with HIV-1 infection.","volume":"351","author":"Lo","year":"1998","journal-title":"Lancet"},{"key":"2023012714365870900_b5","doi-asserted-by":"crossref","first-page":"F37","DOI":"10.1097\/00002030-199806000-00001","article-title":"Indinavir-associated lipodystrophy.","volume":"12","author":"Viraben","year":"1998","journal-title":"AIDS"},{"key":"2023012714365870900_b6","doi-asserted-by":"crossref","first-page":"F51","DOI":"10.1097\/00002030-199807000-00003","article-title":"A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving protease inhibitors.","volume":"12","author":"Carr","year":"1998","journal-title":"AIDS"},{"key":"2023012714365870900_b7","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1042\/bj2600535","article-title":"Sensitive and specific two-site immunoradiometric assays for human insulin, proinsulin. 65\u201366 split and 32\u201333 split proinsulins.","volume":"260","author":"Sobey","year":"1989","journal-title":"Biochem J"},{"key":"2023012714365870900_b8","first-page":"4272","article-title":"Plasma proopiomelanocortin characterizes the aggressivity of ACTH-secreting tumors.","volume":"81","author":"Raffin-Sanson","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"2023012714365870900_b9","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1042\/bj3090697","article-title":"Control of adipocyte differentiation.","volume":"309","author":"Smas","year":"1995","journal-title":"Biochem J"},{"key":"2023012714365870900_b10","first-page":"2403","volume-title":"Textbook of Dermatology","author":"Black","year":"1998","edition":"6th edn"},{"key":"2023012714365870900_b11","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1148\/radiology.142.3.7063685","article-title":"Computed tomography and ultrasonography of the abdomen in congenital generalized lipodystrophy.","volume":"142","author":"Smevik","year":"1982","journal-title":"Radiology"},{"key":"2023012714365870900_b12","first-page":"170","article-title":"Adipose tissue distribution pattern in patients with familial partial lipodystrophy (Dunningan variety).","volume":"84","author":"Garg","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"2023012714365870900_b13","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/S0140-6736(97)11518-5","article-title":"Visceral abdominal-fat accumulation associated with use of indinavir.","volume":"351","author":"Miller","year":"1998","journal-title":"Lancet"},{"key":"2023012714365870900_b14","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2165\/00128415-199806870-00003","article-title":"Lipodystrophy: cause for concern with protease inhibitor therapy?","volume":"713","author":"Elwood","year":"1998","journal-title":"Reactions"},{"key":"2023012714365870900_b15","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/S0140-6736(05)60294-2","article-title":"Buffalo hump in HIV-1 infection. (Letter.)","volume":"352","author":"De Luca","year":"1998","journal-title":"Lancet"},{"key":"2023012714365870900_b16","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1016\/S0140-6736(05)79053-X","article-title":"Severe premature coronary artery disease with protease inhibitors. (Letter.)","volume":"351","author":"Henry","year":"1998","journal-title":"Lancet"},{"key":"2023012714365870900_b17","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1016\/S0140-6736(98)03391-1","article-title":"Pathogenesis of HIV-1 protease inhibitor-associated peripheral lipodystrophy, hyperlipidaemia, and insulin resistance.","volume":"352","author":"Carr","year":"1998","journal-title":"Lancet"},{"key":"2023012714365870900_b18","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1056\/NEJM199806113382417","article-title":"Paronychia and pyogenic granuloma of the great toes in patients treated with indinavir. (Letter.)","volume":"338","author":"Bouscarat","year":"1998","journal-title":"N Engl J Med"},{"key":"2023012714365870900_b19","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1111\/j.1365-2230.1986.tb00439.x","article-title":"Etretinate and the nails (study of 130 cases): possible mechanisms of some side-effects.","volume":"2","author":"Baran","year":"1986","journal-title":"Clin Exp Dermatol"},{"key":"2023012714365870900_b20","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1097\/00002030-199905070-00021","article-title":"Lipodystrophy associated with nevirapine-containing antiretroviral therapies.","volume":"13","author":"Aldeen","year":"1999","journal-title":"AIDS"},{"key":"2023012714365870900_b21","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1097\/00002030-199903110-00004","article-title":"Redistribution of body fat in HIV-infected women undergoing combined antiretroviral therapy.","volume":"13","author":"Gervasoni","year":"1999","journal-title":"AIDS"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2133.2000.03363.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/bjd\/article-pdf\/142\/3\/496\/48940384\/bjd0496.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/bjd\/article-pdf\/142\/3\/496\/48940384\/bjd0496.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T12:28:25Z","timestamp":1676377705000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/142\/3\/496\/6690434"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,3,1]]},"references-count":21,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2000,3,1]]},"published-print":{"date-parts":[[2000,3,1]]}},"URL":"https:\/\/doi.org\/10.1046\/j.1365-2133.2000.03363.x","relation":{},"ISSN":["1365-2133","0007-0963"],"issn-type":[{"value":"1365-2133","type":"electronic"},{"value":"0007-0963","type":"print"}],"subject":[],"published-other":{"date-parts":[[2000,3,1]]},"published":{"date-parts":[[2000,3,1]]}}}